Makes a non-surgical neuromodulation device for children with IBS-related pain.
Industry: Health Care
Latest Trade: $3.13 0.00 (0.0%)
First Day Return: 0.0%
Return from IPO: -47.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/10/2023 |
Offer Price | $6.00 |
Price Range $6.00 - $6.00 | |
Offer Shares (mm) | 1.1 |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/08/2023 |
Offer Price | $6.00 |
Price Range $6.00 - $6.00 | |
Offer Shares (mm) | 1.1 |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Alexander Capital |
Company Data | |
---|---|
Headquarters | Carmel, IN, United States |
Founded | 2011 |
Employees at IPO | 18 |
Website neuraxis.com |